chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had a very congested head and pretty good reaction to it; I had hives; Hives in my mouth, my eyes and my fingers; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection, lot number, expiration date was not reported), via an unspecified route of administration, on an unspecified date, at dose number unknown, single for covid-19 immunization. The patient medical history and concomitant medications were not reported. The patient experienced very congested head and pretty good reaction to it and hives in mouth, eyes, and fingers on an unspecified date. The outcome of the events was unknown.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
got a half dose; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL UNDERDOSE (got a half dose) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ACCIDENTAL UNDERDOSE (got a half dose). At the time of the report, ACCIDENTAL UNDERDOSE (got a half dose) had resolved.            No concomitant medications were not reported. No treatment medications were not provided. Patient got a half dose and that it was because she was above 65 years of age.
SIRVA - Rt shoulder pain. Likely related to improper administration technique into subdeltoid bursa.
irritability, swelling, induration of lt leg from inj site on thigh to below lt knee;
local reaction; one and a half by two inches, raised; erythematous/arm is still red where delayed reaction occurred; intensely pruritic; painful, tender; palpable; started to feel the axillary node on the injection side; A spontaneous report was received from a physician concerning a 69 years old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced started to feel the axillary node on the injection side, painful, tender, palpable, local reaction; one and a half by two inches, raised, erythematous/arm is still red where delayed reaction occurred, intensely pruritic.  Medical history was not provided.  Concomitant medication was not provided.  On 04-Jan-2021, prior to the onset of the events started to feel the axillary node on the injection side, painful, tender, palpable, local reaction; one and a half by two inches, raised, erythematous/arm is still red where delayed reaction occurred, intensely pruritic, the patient received their first of two planned doses of mRNA-1273 (lot/batch: 300042721) via intramuscular route in left arm for prophylaxis of COVID-19 infection.  On 09-Jan-2021, the patient experienced started to feel the axillary node on the injection side, painful and on 10-Jan-2021 experienced painful, tender, palpable, local reaction; one and a half by two inches, raised, erythematous/arm is still red where delayed reaction occurred, intensely pruritic.  Laboratory details was not reported.  Treatment medication included Benadryl and hydrocortisone at an unknown dose and frequency via an unknown route.  Action taken with mRNA-1273 in response to the events started to feel the axillary node on the injection side, painful, tender, palpable, local reaction; one and a half by two inches, raised, erythematous/arm is still red where delayed reaction occurred, intensely pruritic was not provided.  The outcome of the events started to feel the axillary node on the injection side, painful, tender, palpable, local reaction; one and a half by two inches, raised, , intensely pruritic was recovered on 16-Feb-2021 and  the outcome of the event erythematous/arm is still red where delayed reaction occurred was not recovered.  The reporter did not provide the assessment of the events started to feel the axillary node on the injection side, painful, tender, palpable, local reaction; one and a half by two inches, raised, erythematous/arm is still red where delayed reaction occurred, intensely pruritic to study drug.
Patient became delirious, angry, and confused almost immediately after the second vaccine.  He began throwing up at the sight or smell of food.  Symptoms intensified throughout the day and he was taken to urgent care around 8:30-9pm on that same evening.  EKG showed ?Pericarditis? and a CK level of 1,459.  he was in ER overnight and admitted to the hospital on Friday, May 14th.
Rash developed on legs, arms, face.  Redness, swelling and warmth around the eyebrows, nose and ears.  Pt. medicated with po Benadryl in the clinic and observed.
A nurse reported that a patient inadvertently received an intradermal injection of Tetanus Toxoid Adsorbed and subsequently developed redness at the site of the injection. No further info was available at the date of this report. This is 1 of 2 patients from this facility who experienced this event following receipt of an intradermal injection of Tetanus Toxoid.
legs went numb; arms went numb; knees are swollen; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (legs went numb), HYPOAESTHESIA (arms went numb) and JOINT SWELLING (knees are swollen) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038B21A) for COVID-19 vaccination.     Concomitant products included CALCIUM, Centrum Silver, CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), BUPROPION HYDROCHLORIDE (BUPROPION HCL XL), DEXLANSOPRAZOLE (DEXILANT), BUSPIRONE, LAMOTRIGINE, SIMVASTATIN and FAMOTIDINE for an unknown indication.    On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, the patient experienced HYPOAESTHESIA (legs went numb), HYPOAESTHESIA (arms went numb) and JOINT SWELLING (knees are swollen). At the time of the report, HYPOAESTHESIA (legs went numb), HYPOAESTHESIA (arms went numb) and JOINT SWELLING (knees are swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 23-Apr-2021: Non significant Followup Appended
Information has been received from a physician concerning a 72 year old female with hypertension and increased cholesterol who on 30-MAY-2006 was vaccinated with a second dose of Pneumovax 23 (lot # 650302/1039F), subsequently in the upper posterior left arm. There was no concomitant medication. On 01-JUN-2006, "two days after vaccine" the patient developed a cellulitis-like reaction (also reported as cellulitis) posterior left upper arm from site of injection, distally 10 cm with redness, swelling, warmth, induration, mild tenderness. The patient was treated with ice. There were no relevant diagnostic or laboratory tests. The first vaccination of Pneumovax 23 was administered in October 1996. The patient was considered to be recovering. However, it was unknown if the patient recovered. It was noted that the patient had no adverse events following prior vaccinations. Additional information has been requested.
I was admited to the above mentioned Hospital emergency room on 03/08/2007, at 05:29 pm. for minor injury to the eye. The nurse insisted on me getting the DIPHTHERIA/TETANUS VACCINE. I was not given the vaccine information or informed of the risks prior to vaccination.  NP asssured me that vaccine is very safe. Vaccine was adminestered to me, and related printed information was given to me during the discharge on 06:23:35 pm of the same day. I went home and on the same night and woke up 4-6 hours later with sevire paine in the site of injection, in the upper right arm , which progressed in to complete numness of the same arm, followed by the severe fatigue and muscle pain of the back, arms and legs. Six hours later joint inflammation and muscle pain was so severe that it was painful for me to move at all, I started having chills and fever of 100,3 F, dizziness, fatigue and severe pains to the back of the neck in addition to al the above mentioned simptoms. My husband became very concerned, he gave me Ibprofen and took me to Emergency Room on 03/09/2007,at 09:30 pm. I was seen by doctor. I had to be wheeled in the wheel chair, because it was very painful for me to walk and I had a severe fatigue and dizziness. I explained all the above mentioned symptoms, but the doctor keep denying that my illness is vaccination related and I have a case of flu. He recomended plenty of fluids and rest and discharge me. I know he didn't fill out the adverse react. report or contact the first emergency room I was admitted to, because he denies it's vaccine related. Then we came home my husband gave me another dose of Ibprofen and I had to sleep in the recliner, in sitting position, because it was to painfull for me to lay down. I had severe muscle and joint pains for the next 3 days. The numbness in my right arm started to decrease after 3 days, I start slowly using that arm after 5 days. It is been 8 days since reaction to vaccination and I am having arthritis like pains in my joints, especially in my wrists, but NEVER develop any flu or cold. I also call to the hospital that administered the vaccine and reported the severe reaction to vaccination, asking to speak to the doctor and to file the report, the peceptionis told me that doctor can not speak to me right now, then i insisted that doctor need to call me back as soon as possible and left my phone number and message, but nobody have contacted me. I am going to my primary doctor for a pain in my joints and follow up. I want to mention that prior to vaccination I didn't have any illnesses, health conditions or take prescription medication daily. I was in excellent health.
I initially reported to CDC something I believe unrelated to my COVID vaccine--tendonitis in my left wrist, a result of a sports injury.
Severe chills within 1 hour aches shortness of breathe, coughing ,exhaustion, painful breathing  these severe conditions are still prevelant after ten days.
11/12 - Dizzy and heart racing numbness in arms, shaking. Almost passed out at dinner had to be taken home. 11/14 - Symptoms started again, this time arms and hands started drawing up, couldn't breathe, called 911. Went to hospital. Since 11/14, daily occurrences with heart palpitations and can't leave my house or ride in a car.  Always shaky and now have tachycardia.
A couple days after the second dose I experienced increased heart rate that would not stop and increased blood pressure. Even while laying and relaxed my BPM was averaging 100-120 (normal rate 60). It was a couple weeks of this when i finally decided to seek medical help. When i did the doctor thought this might be a longer reaction to vaccine, my body still "fighting". She set me up with a monitoring device that i used for the next 1-2 weeks. So this was about a month of elevated heart rate. Towards the end of the month i would experience periods of rest (60bpm) until finally it stayed there.
pediatric nurse practitioner states they gave some pediatric 6m-5y after the BUD; The vial was initially stored in refrigerator on 23-dec-2022; No adverse event; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (pediatric nurse practitioner states they gave some pediatric 6m-5y after the BUD), PRODUCT STORAGE ERROR (The vial was initially stored in refrigerator on 23-dec-2022) and NO ADVERSE EVENT (No adverse event) in a child patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 216K22A) for COVID-19 prophylaxis.     It was unknown if patient had received any other vaccines in the 4 weeks prior to COVID-19 vaccine.     On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (pediatric nurse practitioner states they gave some pediatric 6m-5y after the BUD), PRODUCT STORAGE ERROR (The vial was initially stored in refrigerator on 23-dec-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (pediatric nurse practitioner states they gave some pediatric 6m-5y after the BUD), PRODUCT STORAGE ERROR (The vial was initially stored in refrigerator on 23-dec-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (pediatric nurse practitioner states they gave some pediatric 6m-5y after the BUD) and PRODUCT STORAGE ERROR (The vial was initially stored in refrigerator on 23-dec-2022).    No concomitant medications were reported.     The pediatric nurse practitioner stated they gave some pediatric 6m-5y after the BUD. Total 42 dose was administered after 30-day Use By Date. The Bivalent 6m-5y vial of 0.4 mL (Lot number: 216K22A) was initially stored in the refrigerator on 23-Dec-2022. The vaccine was administered on 26-Jan-2023, 27-Jan-2023, 30-Jan-2023, 31-Jan-2023 2-Feb-2023, 6-Feb-2023, 8-Feb-2023, 10-Feb-2023, 13-Feb-2023, 14-Feb2-023, 16-Feb-2023, 17-Feb-2023, 21-Feb-2023. The vial did not undergo any temperature excursions.  No treatment medications were reported.  This case contains information for the 42nd of 42 patients described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-718298 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-718298:(Patient no- 1 out of 42 patients)
Flu; Initial information was received on 30-Nov-2022 regarding an unsolicited valid Social Media non-serious case received from a non-health-care professional.  This case involves an unknown age and unknown gender patient who experienced flu after receiving vaccine influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received a dose of suspect influenza vaccine produced by unknown manufacturer (strength, dose, formulation, frequency, lot number and expiry date: not reported) via unknown route in unknown administration site for flu (Influenza).  On an unknown date the patient developed a non-serious event of flu (influenza) (unknown latency) following the administration of influenza vaccine.  It was reported, "I took one in 1972 got sick for our 11 mouths I swear I will never get one again."  Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the event (Flu).  Outcome: Unknown.
This spontaneous report was received from a medical assistant regarding a patient of unknown age and gender. Information on concurrent condition, pertinent medical history and drug allergies of the patient were not reported. On 01-NOV-2011 the patient was vaccinated with first dose of HPV-2 (lot, expiry date, route, dose and anatomical location were not reported) 1 dosage. On 06-JUN-2014, the patient was vaccinated with first dose of GARDASIL lot # J011272, expiry date 21-MAY-2017, 0.5 ml, intramuscular. On 22-JUN-2014, the patient was vaccinated with third dose of GARDASIL lot/batch # K009282, expiry date 06-MAR-2017, 0.5 ml, intramuscular. Concomitant medication were not reported. No adverse effects were reported. There was no Product Quality Concern (PQC) involved. Additional information has been requested.
103.7 temp, chills, headache, body aches - particularly severe at injection site, fatigue
26FEB97 lt arm painful & swollen, warm to touch, pain radiating from lt deltoid area lt chest;
During Rotateq administration, patient choked and apparently aspirated some of the vaccine.  7 days later RML pneumonia febrile.
This spontaneous report was received from a registered nurse refers to an approximately 13 year old female patient. Pertinent medical history and drug reactions or allergies was reported as none. On 10-FEB-2014 at 11:30 AM the patient was vaccinated with GARDASIL lot # H015555 expiry 13-APR-2015 dose number 2 in series, dose: 0.5 ml (milliliters), intramuscular in the right deltoid for vaccination. Concomitant therapy was reported as none. On 11-FEB-2014, the patient presented to doctor office with face that was red, swollen and pruritic. There was no wheezing or throat problems. The patient reported that face swelling occurred at around 7 AM on 11-FEB-2014. The patient was treated with PREDNISONE and ZYRTEC. It was reported that injection site of right deltoid was not red, not swollen and looked fine. Nurse states that she does not know if the reaction was caused by GARDASIL, but thought she would report it. Lab tests were not performed. Product quality complaint was not involved. The outcome of face that was red, swollen, pruritic was reported as not recovered. The causality of the events was not reported. Additional information has been requested.
Bells Palsy right side of face; This is a spontaneous report from a contactable consumer (patient). This 60-year-old female patient (patient was not pregnant at the time of vaccination) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number En6208), via an unknown route on 15Mar2021 at 12:00 pm (at the age of 60-years-old) at single dose on the left arm for COVID-19 immunization. Medical history was none. The patient did not have allergies to medications, food, or other products. Relevant concomitant medications patient received within 2 weeks of vaccination included pantoprazole 40mg. On 15Mar2021 at 12:00, the patient had Bells Palsy right side of face. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No treatment received for the event. Outcome of the event Bells Palsy right side of face was recovered in 2021.   Follow up attempts are needed. Information on the lot/batch number has been requested.
Approximately 30 minutes after COVID vaccine administered, patient reported tongue swelling/itching sensation to tongue and roof of mouth.  This lasted about 15 minutes and resolved on its own without treatment.
Expired vaccine. The expiration in system (states vaccine tracking) was 5/31/22. We were unaware that the use by date was 3/17/22.
Received vaccine on 13:15.  Mom noted urticaria and vomiting about half hour after vaccine.  Seen in office with generalized urticaria, nausea, itching.  No wheeze.  O2 sats 98% RR36.  Gave Benadryl 1 tsp/x 1/5 hours, resolved.
Sore right injection site arm; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (Sore right injection site arm) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033F21A, 010M20A and 013L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INJECTION SITE PAIN (Sore right injection site arm). At the time of the report, INJECTION SITE PAIN (Sore right injection site arm) outcome was unknown.            No concomitant medications were reported. Treatment medication was not provided by the reporter.   This case was linked to MOD-2021-396211, MOD-2021-396318 (Patient Link).
swelling of the left shoulder and pain; swelling of the left shoulder and pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient. A 79-year-old male patient received bnt162b2 (BNT162B2), administration date 01Apr2022 (Lot number: FK9895) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history was not reported. Concomitant medication(s) included: TESTOSTERONE CYPIONATE. Vaccination history included: Bnt162b2 (Dose 1, single), for COVID-19 Immunization; Bnt162b2 (Dose 2, single), for COVID-19 Immunization. The following information was reported: JOINT SWELLING (non-serious), ARTHRALGIA (non-serious) all with onset Apr2022, outcome "unknown" and all described as "swelling of the left shoulder and pain". Additional information: He just got his booster shot of the Pfizer BionTech Covid-19 vaccine (Gray cap per confirmation with Pfizer CS) last Friday and was curious if there was a potential interaction with testosterone injection and viagra. Consumer stated that there was no headache, no flu-like symptoms, and just experienced swelling of the left shoulder and pain. Consumer also stated that he did not experience flu-like symptoms during his initial series of the Pfizer BionTech covid-19 Vaccine shots. Consumer also stated that he takes Testosterone injection 1ML/every other week.
fever 104 less than 24 hr post second dose; This is a spontaneous report from a contactable consumer. A male patient of unspecified age received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown), via an unspecified route of administration on an unknown date, as a single dose for COVID-19 immunisation. The medical history was not reported. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: unknown), via an unspecified route of administration on 25Mar2021, as a single dose for COVID-19 immunisation. Prior to the vaccination, it was unknown if patient was diagnosed with COVID-19. Since the vaccination, it was unknown if the patient had been tested for COVID-19. It was unknown whether the patient received any other vaccines within 4 weeks prior to the COVID vaccine. On an unknown date in 2021, the patient experienced fever 104(unit unspecified) in less than 24 hours after the second dose. It was unknown whether the patient received any treatment for the event. The clinical outcome of the event fever was unknown.   No follow-up attempts are possible; information about lot number cannot be obtained.
This spontaneous report was received from a other health professional refers to an unspecified number of patients of unknown demographics. Patient's pertinent medical history and drug allergies were not reported. On an unknown date, an unspecified number of patients received improperly stored PEDVAXHIB, intramuscular (dose, frequency, route of administration, lot # and expiry date not reported). No symptoms were reported. Outcome of the event was not reported. No product quality complaint (PQC) was reported. Causality was reported as not related to PEDVAXHIB. Additional information has been requested.
LARGE LUMP IN LEFT DELTOID 60MM WIDE: tdap, ADMINISTERED AT THIS SITE.  NO PAIN, NO REDNESS OR BRUISIN.  HAS HAD NO FEVER OR DISCOMFORT. APETITE GOOD RESTING WELL. PATIENT FIRST NOTICED LUMP ON 12-04-208, RECEIVED IMMUNIZATION ON 12-0-2008.